Skip to content

Clinical trials

Metabolic Diseases trials in the United States with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Status: Unknown status Country / region: United States Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20131
20161
20191
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
20Lighter1
Augusta University1
Brigham and Women's Hospital1
Hanmi Pharmaceutical Company Limited1
Massachusetts General Hospital1
Montana State University1
REGENXBIO Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases7
Cardiovascular Diseases3
Hyperlipidemias2
Lysosomal Storage Diseases2
Obesity2
Atherosclerosis1
Cholesterol Ester Storage Disease1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Endocrine System Diseases1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.